Dexcom CEO Kevin Sayer will step down after leading the diabetes tech company for a decade. Current Chief Operating Officer Jake Leach will become CEO on Jan. 1, 2026, and join the firm’s board of directors, according to a Wednesday announcement.
Sayer will help with the transition and remain executive chairman of Dexcom’s board of directors.
Sayer said in a statement that the decision was the result of the board’s succession planning and confidence that Leach is the right leader to continue the company’s growth.
Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May.
Dexcom, which makes continuous glucose monitors, has faced growing competition in the sector, as Abbott expands integrations with automated insulin delivery systems and the Food and Drug Administration authorizes longer-lasting implantable sensors. Dexcom and Abbott last year launched the first over-the-counter glucose sensors.
